Skip to main content
OpenTrials
Completed

NCT Number: NCT04381780

Treatment of Fibromyalgia With Recovery Factors

Treatment of Fibromyalgia and CFS with Recovery Factors

Completed

Looking for future studies?

Notify Me

Key information

About this study

Use of a unique oral porcine peptide nutritional supplement in those meeting ACR 2010(amended) diagnostic criteria for Fibromyalgia or CDC Criteria for CFS

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Meet the ACR 2010 Amended Fibromyalgia Diagnostic Criteria or CFS CDC criteria; Score 5 or less on Energy VAS

Exclusion criteria

Under 18 Pregnant Other severe complicating conditions

-

Treatment and study plan

Recovery Factors

Dietary Supplement

A unique porcine serum based polypeptide nutritional support

Primary outcomes

  1. Composite VAS

    Time frame: 6 weeks

    Composite of VAS for Fatigue, sleep, cognition, pain and overall well being

Secondary outcomes

  1. FIQ-R

    Time frame: 1 month

    Fibromyalgia Impact Questionnaire

Sponsors and collaborators

Lead sponsor

Practitioners Alliance Network

Other

Registry information

Official study title

Treatment of Fibromyalgia With a Unique Polypeptide Nutritional Support

Important dates

Study start
2020
Primary completion
2020
Study completion
2021
First posted
May 11, 2020
Registry last updated
Oct 11, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.